In patients with newly diagnosed AF, early initiation of rhythm control may reduce cardiovascular outcomes. Therapy with antiarrhythmic drugs and/or catheter ablation reduced cardiovascular deaths, strokes, and hospitalizations caused by worsening heart failure or acute coronary syndrome compared with current evidence-based standard care.